Webinar

The Role and Rationale for Oral Options in the Treatment of Metastatic Breast Cancer

Breast cancer oncologists explore more recent advances using oral chemotherapies to treat metastatic breast cancer.

Related Videos
Milind Desai, MD
Masanori Aikawa, MD
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Related Content
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
November 21st 2024

Elevating Value in Cancer Care With Innovations, Accessibility, Equity

Cameron Santoro
Coverage from the IVBM Regional event in Denver, Colorado.
Managed Care Cast
November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi
The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.
CLL over the image of a stethoscope and red blood cells | Image credit: Saiful52 - stock.adobe.com
November 21st 2024

Treating Double-Exposed Patients With CLL: A Continued Unmet Need

Gayle Turim Dickstein
For patients with chronic lymphocytic leukemia (CLL) treated previously with venetoclax and Bruton’s tyrosine kinase inhibitors, many more trials are needed to pinpoint the best next steps
Managed Care Cast
October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi
Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
AML cells concept | image credit: sovova - stock.adobe.com
November 21st 2024

Study Reveals Leukemia Transplant Successes and Persistent Relapse Risks

Kimberly Rath, PharmD
Long-term survival rates for patients with leukemia after hematopoietic cell transplantation (HCT) are encouraging but personalized transplant strategies remain important to improve outcomes.
New research sheds light on the impact of neuronal deficits in SMA | image credit: Muhammed - stock.adobe.com
November 21st 2024

Neuronal Deficit in Severe Infantile SMA Broader Than Previously Thought, Study Finds

Jared Kaltwasser
New research suggests previous assumptions about the pathogenesis of spinal muscular atrophy (SMA) are inadequate.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo